Results 291 to 300 of about 5,282,014 (364)
Body height and the excess cancer risk in men
What's New? In cancers that affect both sexes, men usually have a higher risk than women. While this is often attributed to behavioral factors, such as exposure to environmental carcinogens, there may be an intrinsic biological mechanism involved. Tall stature has been associated with increased cancer risk.
Cecilia Radkiewicz +6 more
wiley +1 more source
Risk factors for postoperative recurrence of differentiated thyroid cancer: a retrospective study. [PDF]
Han S +4 more
europepmc +1 more source
A CASE OF METASTASIS FROM GASTRIC CANCER TO THE THYROID GLAND
Toru Yoshida +5 more
openalex +2 more sources
Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients
What's New? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu +11 more
wiley +1 more source
A Six-Gene Mitochondrial Signature Predicts Prognosis in Dedifferentiated Thyroid Cancer. [PDF]
Lu C, Wang X.
europepmc +1 more source
What's New? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen +17 more
wiley +1 more source
Histopathological, Immunohistochemical, Molecular and Genetic Biomarkers in Differentiated Thyroid Cancer. [PDF]
Al-Abbadi MA +9 more
europepmc +1 more source
What's New? Depression and anxiety are common but often under‐recognized among cancer patients. Using claims data from 14 municipalities in Japan, this study clarified the incidence and temporal trends of these conditions following cancer diagnosis over a 24‐month follow‐up period.
Kengo Kawaguchi +5 more
wiley +1 more source

